ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in ImageneBio, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −5 vs. Q1 2025
- Shares held
- 31.8M
- −985.8K (−3.0%) vs. Q1 2025
- Total value
- $42.6M
- +$646.8K (+1.5%) vs. Q1 2025
- New holders
- 4
- 8 more added
- Sold out
- 9
- 10 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 3 | $4 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 315 | $422 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 500 | $670 | 0.00% | +500 | New |
| Bank of America Corp | 547 | $733 | 0.00% | +326+147.5% | Added |
| JPMorgan Chase & Co | 849 | $1.14K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,275 | $3.05K | 0.00% | +2,275 | New |
| Susquehanna International Group, LLP | 13,141 | $17.6K | 0.00% | +13,141 | New |
| Royal Bank of Canada | 16,000 | $21.0K | 0.00% | +16,000 | New |
| XTX Topco Ltd | 16,999 | $22.8K | 0.00% | −39,453−69.9% | Reduced |
| Berkshire Asset Management LLC | 20,000 | $26.8K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 27,416 | $36.7K | 0.00% | +14,845+118.1% | Added |
| Dimensional Fund Advisors LP | 38,621 | $51.8K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 49,315 | $66.1K | 0.00% | −20,369−29.2% | Reduced |
| Northern Trust Corp | 57,565 | $77.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 58,957 | $79.0K | 0.00% | −20,465−25.8% | Reduced |
| Barclays PLC | 66,177 | $88.7K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 66,664 | $89.3K | 0.00% | −9,800−12.8% | Reduced |
| UBS Group AG | 74,661 | $100.0K | 0.00% | −25,999−25.8% | Reduced |
| Squarepoint Ops LLC | 84,680 | $113.5K | 0.00% | +7,246+9.4% | Added |
| State Street Corp | 92,153 | $123.5K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 144,100 | $193.1K | 0.00% | −7,300−4.8% | Reduced |
| Bridgeway Capital Management, LLC | 153,300 | $205.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 158,215 | $212.0K | 0.00% | +78,528+98.5% | Added |
| Jacobs Levy Equity Management, Inc | 198,107 | $265.5K | 0.00% | −47,378−19.3% | Reduced |
| Acadian Asset Management LLC | 209,568 | $278.0K | 0.00% | 00.0% | Unchanged |
| Aldebaran Capital, LLC | 242,116 | $324.4K | 0.32% | −5,679−2.3% | Reduced |
| Geode Capital Management, LLC | 307,972 | $412.8K | 0.00% | −9,119−2.9% | Reduced |
| Renaissance Technologies LLC | 308,856 | $413.9K | 0.00% | +14,369+4.9% | Added |
| Gilead Sciences, Inc. | 348,534 | $467.1K | 0.04% | −810,611−69.9% | Reduced |
| BlackRock, Inc. | 357,936 | $479.6K | 0.00% | +9,302+2.7% | Added |
| Sofinnova Investments, Inc. | 382,616 | $512.7K | 0.03% | 00.0% | Unchanged |
| NEA Management Company, LLC | 600,063 | $804.1K | 0.06% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 800,000 | $1.07M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,413,649 | $1.89M | 0.00% | +30,231+2.2% | Added |
| Omega Fund Management, LLC | 2,249,123 | $3.01M | 1.95% | 00.0% | Unchanged |
| Deep Track Capital, LP | 2,515,513 | $3.37M | 0.11% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,539,358 | $4.74M | 0.12% | 00.0% | Unchanged |
| BVF Inc | 4,006,564 | $5.37M | 0.19% | 00.0% | Unchanged |
| BML Capital Management, LLC | 4,030,102 | $5.40M | 4.14% | +319,299+8.6% | Added |
| Blue Owl Capital Holdings LP | 4,091,118 | $5.48M | 1.77% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $6.72M | 1.02% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 0 | $0 | 0.00% | −296,437−100.0% | Sold out |
| Deuterium Capital Management, LLC | 0 | $0 | 0.00% | −80,579−100.0% | Sold out |
| BBR Partners, LLC | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −26,000−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −16,952−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −5,063−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −525−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −108−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −69−100.0% | Sold out |